| Nomenclature | OATP2A1 | OATP2B1 | OATP3A1 |
| Systematic nomenclature | SLCO2A1 | SLCO2B1 | SLCO3A1 |
| HGNC, UniProt | SLCO2A1, Q92959 | SLCO2B1, O94956 | SLCO3A1, Q9UIG8 |
| Endogenous substrates | eicosanoids, prostaglandins | T4, dehydroepiandrosterone sulphate, estrone-3-sulphate | BQ123, vasopressin, prostaglandins, thyroid hormones |
| Substrates | synthetic prostaglandin derivatives | telmisartan, glibenclamide, amiodarone, bosentan, BSP, talinolol, aliskiren, fexofenadine, statins | – |
| Inhibitors (pIC50) | bromocresol green, BSP | gemfibrozil, glibenclamide, rifamycin SV | – |
| Radioligands (Kd) | [3H]PGE2 | [3H]BSP, [3H]estrone-3-sulphate | [3H]estrone-3-sulphate, [3H]PGE2 |
| Comment | Other inhibitors include NSAIDs | Other inhibitors include glitazones and citrus juices | – |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.